45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,151
Insurances with rates
16
CPT / HCPCS codes
2,020
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 9274 | Antivenin, Crotalidae FAB 1 GM SDVial | $41,769 | $16,708 | — | — | 16 |
| J0840 | Antivenin, Crotalidae FAB 1 GM SDVial | $41,769 | $16,708 | — | — | 16 |
| 63650 | NERVE STIMULATOR | $33,383 | $13,353 | — | — | 18 |
| Q4108 | SKIN SUB, Integra MATRIX 4x5 | $26,017 | $10,407 | — | — | 16 |
| 1489 | Vedolizumab 300 mg inj (Entyvio) | $24,220 | $9,688 | — | — | 16 |
| J3380 | Vedolizumab 300 mg inj (Entyvio) | $24,220 | $9,688 | — | — | 16 |
| 7048 | Alteplase 100 mg SDVial | $24,198 | $9,679 | — | — | 16 |
| J2997 | Alteplase 100 mg SDVial | $24,198 | $9,679 | — | — | 16 |
| 1687 | DIGOXIN IMMUNE FAB IV 40MGVIAL | $22,760 | $9,104 | — | — | 16 |
| J1162 | DIGOXIN IMMUNE FAB IV 40MGVIAL | $22,760 | $9,104 | — | — | 16 |
| J2505 | Pegfilgrastim 6mg / 0.6 ML Neulasta | $21,491 | $8,596 | — | — | 16 |
| 275 | PACEMARKER ACID | $21,225 | $8,490 | — | — | 16 |
| C1785 | PACEMARKER ACID | $21,225 | $8,490 | — | — | 16 |
| 9126 | Natalizumab 300 mg IVPB (Tysabri) | $19,861 | $7,944 | — | — | 16 |
| J2323 | Natalizumab 300 mg IVPB (Tysabri) | $19,861 | $7,944 | — | — | 16 |
| 9002 | Tenecteplase 50 mg SDVial | $17,101 | $6,840 | — | — | 16 |
| J3101 | Tenecteplase 50 mg SDVial | $17,101 | $6,840 | — | — | 16 |
| Q4101 | APLIGRAF | $14,979 | $5,992 | — | — | 16 |
| 33210 | TEMPORARY TRANSVENOUS PACER | $14,635 | $5,854 | — | — | 19 |
| J9310 | Rituxan 500 mg IVPB | $13,145 | $5,258 | — | — | 16 |
| 43632 | REM STOMACH, PARTIAL | $12,867 | $5,147 | — | — | 19 |
| 1207 | Sandostatin Lar Dep 20 MG VL | $12,794 | $5,118 | — | — | 16 |
| J2353 | Sandostatin Lar Dep 20 MG VL | $12,794 | $5,118 | — | — | 16 |
| 45110 | REMOVAL OF RECTUM | $11,858 | $4,743 | — | — | 19 |
| 45114 | PARTIAL REM OF RECTUM | $11,536 | $4,614 | — | — | 19 |
| Q4106 | GRAFT DERMA SPAN 4X8 | $11,021 | $4,408 | — | — | 16 |
| 44143 | PARTIAL REM OF COLON | $10,610 | $4,244 | — | — | 19 |
| 44626 | REPAIR BOWEL OPENING | $10,228 | $4,091 | — | — | 19 |
| 48140 | PARTIAL REMOVAL PANCREAS | $9,922 | $3,969 | — | — | 19 |
| 27130 | HIP ARTHROPLASTY, TOTAL | $9,484 | $3,794 | — | — | 19 |
| 27447 | KNEE ARTHROPLASTY, TOTAL | $9,474 | $3,790 | — | — | 19 |
| 1083 | Adalimumab 40mg/0.8nl | $9,237 | $3,695 | — | — | 16 |
| J0135 | Adalimumab 40mg/0.8nl | $9,237 | $3,695 | — | — | 16 |
| C1776 | IMPLANT KNEE | $8,640 | $3,456 | — | — | 16 |
| J3110 | Teriparatide PEN 750mg/3ml | $7,924 | $3,170 | — | — | 16 |
| 81211 | BRCA 1&2 SEQ & COM DUP/DEL | $7,914 | $3,166 | — | — | 16 |
| 50230 | REM KIDNEY OPEN RADICAL | $7,855 | $3,142 | — | — | 19 |
| 44120 | REM OF SM INTESTINE | $7,771 | $3,108 | — | — | 19 |
| 9272 | Prolia 60mg/ml | $7,712 | $3,085 | — | — | 16 |
| J0897 | Prolia 60mg/ml | $7,712 | $3,085 | — | — | 16 |
| J0130 | Abciximab INJ 2MG / 1ML | $7,517 | $3,007 | — | — | 16 |
| L8641 | IMPLANT, METAL HEMI TOE | $7,462 | $2,985 | — | — | 16 |
| 28575 | DISLOCATION REDUCTION TALO-TARSAL WITH A | $7,376 | $2,950 | — | — | 19 |
| Q4107 | GRAFT JACKET 4X4 86-TM-4X04 | $7,337 | $2,935 | — | — | 16 |
| 49565 | REPAIR VENTRAL HERNIA REDUCE | $7,265 | $2,906 | — | — | 19 |
| J3490 | SEVOFLURANE 250 ML ALUMINIUM | $7,149 | $2,860 | — | — | 16 |
| 15935 | REM SACRUM PRES SORE | $7,110 | $2,844 | — | — | 19 |
| 47600 | REMOVAL OF GALLBLADDER | $6,786 | $2,714 | — | — | 19 |
| 47605 | REMOVAL OF GALLBLADDER | $6,786 | $2,714 | — | — | 19 |
| 1689 | Fomepizole 1GM/ /ML 1.5 ML VL | $6,504 | $2,602 | — | — | 16 |
Showing top 50 of 2,151 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.